The Difference Between Learning Disabilities and ADHD

Weighing telepsychiatry vs in-person care means holding two findings at once. Across many mental health conditions, video psychiatry performs about as well as sitting in the same room. For severe mental illness (SMI) such as schizophrenia and bipolar disorder, the trials simply have not been run, and parts of this care (injections, blood tests, physical checks, and crisis assessment) cannot travel through a screen at all. So the real question is rarely either-or. It is which parts of care can safely go virtual, which parts cannot, and who should be making that call as your stability changes over time. Here's what the research shows, and where the practical limits fall.

What Telepsychiatry Is and What In-Person Care Means

Telepsychiatry is psychiatric care delivered by video or phone: evaluations, medication visits, and therapy sessions held from wherever the patient is. In-person care means visits at a clinic, with the clinician and everything a clinic contains (labs, injections, vitals, a team down the hall) physically present. Between them sits hybrid care, a deliberate mix of both formats, which is how a great deal of psychiatric care in the United States now actually runs. The terms matter less than what each format can physically deliver, which is where the comparison gets concrete.

What the Research Shows

The broadest comparison to date is a 2023 meta-analysis in the British Journal of Psychiatry covering 32 randomized trials and 3,592 participants across 11 conditions (Hagi et al., 2023). Pooled together, there was no significant overall difference in symptom improvement between telepsychiatry and face-to-face treatment. By condition, telepsychiatry did better for depressive disorders, across 6 trials, and face-to-face did better for eating disorders, on the strength of a single trial. Dropout findings split the same way, each direction supported by one small study. Several of the condition-level results rest on a single trial, which makes them fragile rather than final, and the authors note as much.

That finding cuts in both directions. Video care is not a watered-down version of psychiatry; for depression in particular it holds up well, and dismissing it would misread the data. At the same time, a pooled average across 11 conditions says nothing about the conditions that never made it into the trials, and the trials skew toward the diagnoses that are easiest to study remotely.

What We Know, and Do Not Yet Know, About SMI

Schizophrenia and bipolar disorder are largely missing from this evidence. A 2022 systematic review in JMIR Mental Health went looking for randomized trials of telehealth psychotherapy and found 12 trials with 931 patients, none of which studied schizophrenia or bipolar disorder, leading the authors to call for high-quality research before treating telehealth as equivalent for these conditions (Greenwood et al., 2022). The Hagi meta-analysis likewise names neither condition among its findings. Narrative reviews describe telehealth with psychosis as feasible and acceptable, and feasibility is a different claim than tested equivalence.

The absence of strong trials is not proof that telepsychiatry harms people with severe mental illness, and it is not proof of equivalence either. For conditions this serious, that gap counsels care in what gets moved online, and it puts the burden on care models to show their format choices serve the patient rather than the schedule.

What Needs to Happen In Person

Some components of SMI treatment are physical, and no quality of webcam changes that:

• Long-acting injectable antipsychotics are administered by a clinician, on a schedule, in person. For many people they are the backbone of stability.
• Blood monitoring comes with several core SMI medications: lithium levels, the regular blood counts recommended with clozapine, and metabolic monitoring for people on antipsychotics, per each medication's prescribing requirements. These need a clinic or a lab, not a login.
• Physical exams and vitals catch the medical problems that psychiatric medications can cause and that psychiatric illness so often hides from everyone, including the patient.
• Interventional treatments such as TMS and Spravato are delivered in clinic under supervision, by design.
• Crisis assessment is a hands-on clinical skill. Judging safety through a screen, with a person who may not want to be seen clearly and can end the call at will, is a genuinely harder task than assessing someone in the room.

For severe mental illness, these are routine, recurring parts of treatment rather than rare events, which is why fully remote care for this population runs into walls that have nothing to do with anyone's opinion of telehealth. A care plan that includes an injectable every four weeks and quarterly labs has an in-person spine no matter how the conversations happen.

Where Telepsychiatry Fits Well

Video visits earn their place in several situations: stable follow-ups and medication check-ins once a plan is working, access for people who live far from psychiatric care or cannot travel easily, and flexibility for family members joining a session from different places. For a routine fifteen-minute medication review in a stable month, driving an hour each way serves nobody.

Those are real advantages, and they come with real conditions. A video visit requires privacy at home, which not every household offers, a reliable connection, and the ability to engage through a screen, each of which gets harder exactly when symptoms are most active. Paranoia can make a camera feel threatening; depression can make logging in feel impossible. The format works best for the stable stretches of an illness that does not always stay stable.

Hybrid Care and Level of Need

The workable frame is level of need rather than loyalty to a format. Someone newly stabilized after a hospitalization needs more in-person contact: labs, physical checks, possibly injections, a team reading them closely. Someone two stable years into treatment may handle routine visits by video and come in for bloodwork and periodic full evaluations. A rough month might mean temporarily moving visits back on site.

The mix should shift as stability shifts, in both directions, and the people best positioned to adjust it are a care team who knows the whole picture, the same logic that separates outpatient from inpatient levels of care.

Why a Coordinated, In-Person Team Matters for SMI

Severe mental illness is a whole-body, whole-life illness, and people living with it face higher rates of serious physical illness, so treating it takes more than a sequence of appointments in any format. At Amae Health, one team (psychiatrists, therapists, and primary care physicians, along with peer mentors, care coordinators, dietitians, and health coaches) works from a shared plan in one place, so the injection, the lab draw, the therapy session, and the medical follow-up belong to one plan rather than four calendars. That is the part of care a screen cannot substitute for: not the conversation, which video carries fine, but the coordination and the physical medicine around it. It is the model behind our psychosis care and bipolar disorder treatment, and our full care model shows how the pieces fit.

Talking to Our Care Team About the Right Format

The right format is a clinical question with a moving answer: it depends on your current symptoms, your medications and their monitoring, your stability, and your goals. A first conversation can settle where to start and how to adjust from there. Reach out to our care team about the right format for this stage, and our patient and family resources describe what coordinated care involves.

Frequently Asked Questions

Is telepsychiatry as effective as in-person psychiatry?

For many conditions, yes. A 2023 meta-analysis of 32 randomized trials found no significant overall difference in symptom improvement, and telepsychiatry did best for depressive disorders. Results vary by condition, and evidence for schizophrenia and bipolar disorder specifically is limited.

Is telepsychiatry effective for schizophrenia?

The research is thin. A 2022 systematic review found no eligible randomized trials of telehealth psychotherapy for schizophrenia, while narrative reviews describe telehealth with psychosis as feasible and acceptable. Limited research is the accurate summary, not evidence of failure.

Can long-acting injectable antipsychotics be given by telehealth?

No. Injections are administered in person by a clinician, so people on long-acting injectables need in-person visits on their injection schedule, whatever else happens by video.

Do I need blood tests or physical checks with serious mental illness?

Often, yes, depending on the medication. Lithium requires blood level checks, clozapine calls for regular blood monitoring, and antipsychotics call for metabolic monitoring under their prescribing requirements, all of which involve a clinic or lab visit.

Can telepsychiatry handle a mental health crisis?

No. Video visits are not built for emergencies. In a crisis, call or text 988 or go to the nearest emergency room; a care team can take over treatment planning once the person is safe.

What is hybrid psychiatric care?

A deliberate mix of in-person and video visits, adjusted over time as stability and needs change. In-person time covers the parts of care that require presence, such as injections and labs, while routine check-ins can happen by video.

What if I am having thoughts of suicide?

Help is available right now, at any hour: call or text 988 for free, confidential support.

Citations

1. Hagi K, et al. "Telepsychiatry versus face-to-face treatment: systematic review and meta-analysis of randomised controlled trials." British Journal of Psychiatry, 2023;223(3):407-414. doi.org/10.1192/bjp.2023.86. Tier 1 (peer-reviewed meta-analysis).
2. Greenwood H, et al. "Telehealth versus face-to-face psychotherapy for less common mental health conditions: systematic review and meta-analysis." JMIR Mental Health, 2022;9(3):e31780. PMC8956990. Tier 1 (peer-reviewed systematic review).
3. 988 Suicide and Crisis Lifeline. 988lifeline.org. Tier 2 (FAQ only).

Bipolar disorder changes the weather inside a life. Mood swings disrupt work, sleep, relationships, and the sense that next month will look anything like this one. The emotional exhaustion of cycling through episodes and the strain those episodes put on close relationships are part of why so many patients describe bipolar disorder as harder to live with than almost any other condition they know. Medication is usually the foundation of treatment. But medication alone is rarely enough. Bipolar disorder supportive therapy is one of several psychotherapy approaches that sit alongside medication to turn stability into an actual life.

‍

This guide explains what supportive therapy is, how it fits alongside other therapies, and what kind of help may improve day-to-day stability.

What Is Supportive Therapy For Bipolar Disorder?

Supportive therapy is a psychotherapy approach built around emotional support, trust, validation, and practical coping. It does not focus on deep analysis of the unconscious, and it is not a structured skills protocol. It is the kind of therapy where a clinician listens carefully, helps you make sense of what you are feeling and going through, reinforces what is working, and helps you solve the next problem in front of you.

‍

Supportive therapy is almost always part of a broader treatment plan for bipolar disorder, not a replacement for psychiatric care. Most people combine it with medication management, and many eventually layer in more structured approaches like CBT or family-focused therapy.

What Techniques Are Used in Bipolar Disorder Supportive Therapy

The practical tools a supportive therapist uses include:

‍

• Emotional validation that acknowledges the real weight of what the person is experiencing
• Active listening that slows down and surfaces what is actually going on, not just the surface complaint
• Psychoeducation about the illness cycle, warning signs, and what to expect
• Problem-solving on concrete day-to-day stressors, from a difficult conversation to a medication side effect
• Strengthening insight about mood patterns and personal triggers
• Reinforcing engagement in the full treatment plan, including appointments and medication

How Supportive Therapy Helps People With Bipolar Disorder

Emotional Support During Mood Instability

Mood episodes are disorienting. A depressive stretch can last weeks, a hypomanic period can feel like the most productive month of your life until it crashes, and a mixed episode can fold both into the same week. Supportive therapy gives a person somewhere to bring that weight, week after week, with someone who understands what bipolar disorder looks like from the inside. That consistency alone steadies many patients through the worst stretches.

Building Coping Skills And Daily Stability

The practical work of staying well with bipolar disorder is mostly about routines. Supportive therapy helps people build and protect them:

‍

• Consistent sleep and wake times, because sleep disruption is a common trigger
• Strategies for stress management when life gets loud
• Conflict management skills for relationships under strain
• Recognizing early warning signs of an episode so they can be interrupted

Supporting Medication Adherence And Ongoing Care

Medication is the foundation of bipolar treatment. But it can also be hard to stay on. Side effects, the feeling of missing hypomanic energy, the belief that symptoms will not return, and plain forgetfulness all contribute to the high discontinuation rates that research keeps finding. Supportive therapy gives people a place to talk honestly about their fears and frustrations with medication, think through side effects with a trusted clinician, and stay engaged when the usual instinct would be to drop out.

Supportive Therapy vs. Other Therapy Approaches

Supportive therapy is one of several psychotherapy approaches with evidence for bipolar disorder. A quick comparison:

A large systematic review of 39 randomized trials of adjunctive psychotherapy for bipolar disorder found that family-focused, cognitive behavioral, and psychoeducational therapies reduced episode recurrence compared with usual treatment (Miklowitz et al., JAMA Psychiatry, 2021).

When Other Therapies May Be Added

Supportive therapy is often the right starting point, especially after a new diagnosis or during stabilization. Over time, many patients add a more structured approach:

‍

• CBT for persistent depressive symptoms or to build relapse-prevention skills
• DBT for patients with heavy emotional reactivity or co-occurring BPD features
• IPSRT for people whose episodes are tied to disrupted sleep and routines
• Family-focused therapy when relationship dynamics are shaping the illness course

‍

The choice depends on symptoms, goals, and what the person actually needs at that stage. A skilled clinician will adjust the approach as the picture changes.

What To Expect In Bipolar Disorder Supportive Therapy

Sessions are usually 45 to 50 minutes and are typically weekly at the start. The work is conversational rather than homework-driven. A session might open with what happened that week, look at mood patterns since the last visit, surface any new stressors, and end with a small plan for the week ahead.

‍

The clinician will pay attention to warning signs: sleep changes, energy shifts, spending or relationship patterns, and medication side effects. Over time, a person in supportive therapy often becomes much better at tracking their own mood, which makes the intervals between episodes longer and the episodes themselves shorter.

Who May Benefit Most

Supportive therapy tends to help most for:

‍

• People newly diagnosed who need to make sense of what bipolar disorder is and what the next year can look like
• People adjusting to treatment who are figuring out medication, routines, and how to communicate about the illness
• People navigating the emotional fallout of a recent episode, including shame, regret, or strain with family
• People in long-term stabilization who want a steady clinician presence without intensive protocols

‍

It is less of a match for patients who need heavy skills training for severe emotion dysregulation or those in active crisis, where higher levels of care are indicated.

When To Seek Professional Help For Bipolar Disorder

A few questions to ask yourself:

‍

• Are mood episodes interfering with work, school, or close relationships?
• Has your sleep pattern changed significantly for more than a week?
• Are you making impulsive decisions that later feel hard to explain?
• Is someone close to you saying your behavior feels out of character?
• Are you having thoughts of self-harm or suicide?

‍

If the answer to any of these is yes, it is worth calling a clinician. For immediate safety concerns, call 988 for the Suicide and Crisis Lifeline.

Bipolar Disorder Care At Amae Health

At Amae Health, we support individuals battling bipolar disorder. Our approach is integrated: psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors, and clinical care coordinators all work from one shared treatment plan. That structure matters for bipolar disorder, because the condition touches sleep, physical health, medication, and relationships at the same time, and fragmented care usually misses something.

‍

If bipolar symptoms are disrupting daily life for you or someone you love, we can help with evaluation, treatment planning, and ongoing support. Learn more about our bipolar disorder care, read our guide to the most effective treatments for bipolar disorder, or call 1-888-860-2825 to start the conversation.

‍

Citations

1. Miklowitz et al., "Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis," JAMA Psychiatry, 2021. Tier 1 (peer-reviewed).

‍

Finishing a course of TMS and feeling like yourself again brings a new worry: will it hold? How long do TMS results last, and what happens if the depression comes back? The research is more encouraging than many people expect. Among people who respond to a course, roughly half to nearly two-thirds are still responding a year later, and when symptoms do return, restarting TMS brought back the improvement for most people in the research.

‍

None of that predicts any one person's course. It does show what tends to help results last, and why the months after treatment deserve a plan of their own.

What "Lasting" Means: Response vs. Remission

Two terms do most of the work in durability research. A person has responded when their depression scores fall by at least half on a standard rating scale. They're in remission when scores drop low enough that the depression is largely gone.

‍

Durability studies then ask a narrower question than the original trials did: of the people who responded or reached remission by the end of a course, how many were still doing well months later? That framing matters when you read the numbers. A result such as 62.5% of people keeping their response for a year describes people who had already responded, not everyone who started TMS. Those follow-up checks happen at set points, typically three, six, and 12 months after a course, so durability is reported as the share of people still responding at each checkpoint.

What the Research Shows About Durability

The most direct data come from a 2014 study in The Journal of Clinical Psychiatry that followed people with medication-resistant major depression for a year after they finished TMS at 42 U.S. clinical practices. Of the 257 people who completed a course and agreed to follow-up, 120 had responded or reached remission by the end of treatment. Of those 120, 75 (62.5%) kept meeting response criteria through the full 12 months.

‍

Two details shape that result. The study used a practical approach after the course: continued antidepressant medication, plus access to more TMS if symptoms returned. And over the year, 93 participants (36.2%) had TMS reintroduced at some point, averaging about 16 treatment days. So the 62.5% reflects TMS inside ongoing care, not a single course left to stand on its own.

‍

A 2019 meta-analysis in Brain Stimulation pooled 19 studies of people who had responded to a TMS course. About two-thirds were still responding at three months, about 53% at six months, and about 46% at one year. The authors' summary: roughly half of responders keep their response for up to a year after a successful course.

‍

Read together, the two studies give a realistic range of around half to nearly two-thirds of responders still doing well a year out. The other side of those numbers matters just as much. A meaningful share of people see symptoms return within the first year, and planning for that possibility is part of good care, not a sign that treatment failed.

Factors That Influence How Long Results Last

The research has identified a few patterns, mostly at the level of groups rather than individuals:

‍

• Maintenance treatment. In the 2019 meta-analysis, studies that included maintenance treatment showed higher sustained response at some time points.
• The mix of people studied. Studies with a higher proportion of women also showed higher sustained response, a group-level pattern that says nothing reliable about any one person.
• Continued medication. The best-known durability results come from people who stayed on antidepressants after TMS, so those numbers describe that combination.
• A completed course. Durability figures come from people who finished a full acute course. They don't describe what happens after a partial one.

‍

Clinicians also weigh a person's history when planning follow-up, such as how many depressive episodes they've had and how many treatments failed before TMS. The findings above don't establish how much those factors change the odds, so they inform a clinician's judgment rather than supply a number.

Maintenance TMS: What It Is and Who May Need It

TMS maintenance treatment means periodic sessions after the main course, scheduled to protect a response rather than to answer a relapse. Schedules vary between providers and between people, and no single schedule has become standard.

‍

The evidence supports the idea without settling the details. The 2019 meta-analysis found maintenance associated with more durable response, and its authors suggested maintenance be considered in practice and tested in future trials. That's a promising signal, not a proven protocol. Maintenance TMS is also separate from staying on medication: in both the year-long and six-month studies, people continued antidepressants whether or not they received more TMS.

‍

Not everyone needs it. Some people stay well for long stretches without it. Whether maintenance makes sense for a particular person is a judgment a psychiatrist makes from their history and how they're doing in the months after the course.

Can TMS Be Repeated If Symptoms Return?

Yes, and the research on restarting TMS is among the most reassuring parts of this topic. In a six-month study in Brain Stimulation, people whose depression had improved by at least a quarter with TMS stopped treatment gradually over three weeks while starting maintenance antidepressant medication. In that study, worsening had a specific meaning: a clinician-rated decline that held for two consecutive weeks, which triggered restarting TMS. Over the next 24 weeks, 38% had symptoms worsen enough to restart TMS, and 32 of those 38 people (84%) regained their improvement. Only 10% of the 99 people whose results were reported met the study's definition of relapse.

‍

A repeat course is different from maintenance. Maintenance is planned in advance to hold a response; a repeat course starts because symptoms have come back. In the year-long study described above, about a third of participants had TMS reintroduced at some point. Whether and when to restart is a decision made with a psychiatrist, based on how symptoms are changing.

What Helps Results Last Longer

Beyond maintenance and continued medication, two more things help, though neither promises that results will last for a particular person:

‍

• Catching changes early. In the six-month study, regular assessments flagged worsening symptoms, and most people who restarted TMS at that point regained their improvement.
• Staying connected to care. Therapy and regular psychiatric visits mean someone is watching for early changes between treatments.

‍

Knowing what returning depression tends to look like makes early changes easier to catch: shifts in sleep or appetite, lower energy, less interest in usual activities, and a low mood that lingers instead of lifting after a few days. When those signs show up, reaching out sooner gives a care team more options, and our guide on how to ask for help when depressed covers how to start that conversation.

‍

These describe what research associates with better long-term results in groups of patients. They aren't instructions for any one person's treatment plan; that's a psychiatrist's call, made with the whole history in view.

Talking to a Psychiatrist About a Long-Term Plan

A TMS course is the start of a plan, not the end of one. The months afterward are when follow-up, medication decisions, and a clear plan for what happens if symptoms return matter most.

‍

At Amae, TMS sits inside our integrated care model, where psychiatric care, therapy, primary care, and peer support stay linked after the course ends. We provide TMS therapy for major depressive disorder at our Los Angeles clinic and at our Bay Area clinics in Los Altos and San Mateo. Commercial insurance plans and cash pay are both accepted, and our intake team handles prior authorization. To map out what comes after a course, talk with an Amae psychiatrist about a long-term plan. Anyone in crisis can reach the 988 Suicide and Crisis Lifeline by call or text.

Frequently Asked Questions

How long do TMS results typically last?

For many people, months to a year or longer, though it varies. In a year-long study of people who responded to TMS, 62.5% kept meeting response criteria for the full 12 months. A 2019 meta-analysis found that about half of responders were still responding at one year.

What percentage of people relapse after TMS?

Some return of symptoms within a year is common. In the 2019 meta-analysis, roughly half of responders were no longer responding at one year. That isn't always a full relapse: in a six-month study, 38% had symptoms worsen enough to restart TMS, while 10% met the study's definition of relapse.

Can TMS be repeated if depression comes back?

Yes. In a six-month study, 84% of people whose symptoms worsened regained their improvement when TMS was restarted. A repeat course is different from ongoing maintenance sessions, and the decision is made with a psychiatrist based on individual history.

Do I need maintenance TMS sessions after my initial course?

Not necessarily. Some people stay well without them, and there is no standard maintenance schedule across providers. Research links maintenance with longer-lasting response, so whether it fits is a decision a psychiatrist makes based on your response and how closely symptoms are being monitored.

What can help TMS results last longer?

The research points to planned follow-up, continued medication when it's part of the plan, and catching symptom changes early. These are general findings from groups of patients, not instructions for any one person's treatment.

Is maintenance TMS covered by insurance?

It depends on the insurer and on whether sessions are billed as maintenance or as a new course for returning symptoms, since coverage can differ between the two. Ask the provider to verify benefits with your insurer before sessions begin.

‍

Citations

1. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. Journal of Clinical Psychiatry. 2014;75(12):1394-1401. https://pubmed.ncbi.nlm.nih.gov/25271871/
2. Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimulation. 2019;12(1):119-128. https://pubmed.ncbi.nlm.nih.gov/30344109/
3. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation. 2010;3(4):187-199. https://pubmed.ncbi.nlm.nih.gov/20965447/
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍